Mucosal immunity in the upper respiratory tract is central to preventing influenza infection. Investigators collected palatine tonsils from children and adults undergoing tonsillectomy to examine tissue-level responses after intranasal LAIV. The study team applied quantitative immunofluorescence microscopy to map germinal centre morphology and mantle zone areas, and to count IgG- and IgA-positive cells within those defined compartments. They also developed an in-situ staining method to identify hemagglutinin-binding cells in paraffin-embedded tonsillar sections.
Children and adults were studied separately. The cohort showed age-dependent structural dynamics: three days after vaccination, the child group displayed smaller-appearing germinal centre areas while antibody-positive cell frequencies peaked. Adults, by contrast, showed progressive increases in germinal centre size and in IgG and IgA cell frequency as time from vaccination increased. Mantle zone areas rose after vaccination in both age groups, indicating a common element of lymphoid architectural remodeling.
The investigators detected hemagglutinin-binding cells within tonsillar tissue using their in-situ staining approach. In some specimens, these antigen-binding cells co-localized with IgA, suggesting that class-switched mucosal antibody responses arise at the site of secondary lymphoid organization. The authors reported these findings qualitatively in the abstract; precise counts, proportions, or statistical measures were not provided in the abstract text.
Data indicated that pre-existing immunity shaped the tempo and apparent mechanism of the response. The cohort showed patterns consistent with two models: children appear to mount rapid de novo germinal centre formation with early class switching to IgG and IgA, whereas adults appear to expand preexisting germinal centres and show a slower, time-dependent rise in antibody-positive cells. Investigators noted these age-related differences in kinetic profiles as central to their interpretation of how prior immune experience modulates mucosal lymphoid architecture following LAIV.
The study used quantitative immunofluorescence microscopy to measure germinal centre and mantle zone architecture and to localize IgG- and IgA-positive cells within those compartments. The authors also implemented an in-situ staining protocol for detecting hemagglutinin-binding cells in paraffin-embedded tonsillar sections. The abstract did not include full methodological parameters such as staining reagents, image-analysis thresholds, or the complete sequence of timepoints beyond the three-day observation cited for children; detailed methods are likely in the full text.
Three days after vaccination the child cohort showed smaller-appearing germinal centres and concurrent peaks in IgG and IgA-positive cell frequencies, suggesting rapid local class switching and nascent germinal centre activity. Adults exhibited a different temporal pattern: germinal centre sizes and antibody-positive cell frequencies increased gradually with increasing time post-vaccination. Mantle zone areas increased in both children and adults, indicating an architectural response common to both age groups despite divergent germinal centre kinetics.
The authors interpreted these observations to mean that pre-existing immunity influences mucosal immune kinetics after intranasal LAIV. Specifically, children—presumed to have less prior influenza exposure—rapidly generate new germinal centres and class-switched antibodies at the tonsillar site. Adults—who are more likely to carry previous exposure and memory—tend to expand existing germinal centres with a slower accumulation of IgG and IgA cells. The presence of hemagglutinin-binding cells, sometimes co-localized with IgA, supports antigen-specific mucosal responses within secondary lymphoid tissue.
The abstract did not report participant counts, exact ages or demographics, nor did it provide quantitative statistics or p-values for the observed differences. It also did not specify the full timepoint schedule beyond the three-day observation for children, and it did not include details of the in-situ staining protocol or image analysis metrics. Those methodological and numerical details were not provided in the abstract and would need to be consulted in the full text.
The study leaves several practical questions open: which precise timepoints define the adult kinetic rise, how durable are the observed mucosal class-switched responses, and to what extent tissue findings predict protection against infection. The abstract does not report whether the authors plan confirmatory or longitudinal clinical follow-up studies; such next steps and any regulatory milestones are not described in the abstract. The absence of participant-level numbers and full statistical reporting in the abstract limits assessment of effect size and generalizability until the full article is reviewed.
Conflict of interest statement: the authors declared funding support for one or more authors from the Influenza Centre at the University of Bergen, Haukeland University Hospital, the Norwegian Ministry of Health and Care Services, The Research Council of Norway (Globvac), and IHI Inno4vac, as reported in the abstract.